All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| CPRX / Catalyst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| MLNT / Melinta Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
| TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| NVLN / NOVELION THERAPEUTICS INC. Call
|
|
|
|
|
|
|
|
| MLNT / Melinta Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SCMP / Sucampo Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| G0083B108 / Actavis
|
|
|
|
|
|
|
|
| G0083B108 / Actavis Call
|
|
|
|
|
|
|
|
| POZN / Pozen, Inc. Call
|
|
|
|
|
|
|
|
| LGND / Ligand Pharmaceuticals Incorporated
|
|
|
|
|
|
|
|
| BIS / ProShares Trust - ProShares UltraShort Nasdaq Biotechnology
|
|
|
|
|
|
|
|
| AUXL / Auxilium Pharmaceuticals Inc Call
|
|
|
|
|
|
|
|
| CLSN / Imunon Inc
|
|
|
|
|
|
|
|
| NVLN / NOVELION THERAPEUTICS INC.
|
|
|
|
|
|
|
|
| TWM / ProShares Trust - ProShares UltraShort Russell2000
|
|
|
|
|
|
|
|
| AMRI / Albany Molecular Research, Inc.
|
|
|
|
|
|
|
|
| AMRI / Albany Molecular Research, Inc. Call
|
|
|
|
|
|
|
|
| VXX / iPath Series B S&P 500 VIX Short-Term Futures ETN Call
|
|
|
|
|
|
|
|
| ZGNX / Zogenix Inc
|
|
|
|
|
|
|
|
| VIRX / Viracta Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
| ANIP / ANI Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CRY / Artivion Inc
|
|
|
|
|
|
|
|
| SRNE / Sorrento Therapeutics, Inc.
|
|
|
|
|
|
|
|
| DGX / Quest Diagnostics Incorporated
|
|
|
|
|
|
|
|
| STML / Stemline Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CLVS / Clovis Oncology Inc
|
|
|
|
|
|
|
|
| ALIM / Alimera Sciences, Inc.
|
|
|
|
|
|
|
|
| ALIM / Alimera Sciences, Inc. Call
|
|
|
|
|
|
|
|
| 17K / Self Storage Group ASA
|
|
|
|
|
|
|
|
| RIGL / Rigel Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| AZN / AstraZeneca PLC - Depositary Receipt (Common Stock) Call
|
|
|
|
|
|
|
|
| MRK / Merck & Co., Inc. Call
|
|
|
|
|
|
|
|
| FCSC / Fibrocell Science Inc.
|
|
|
|
|
|
|
|
| BMY / Bristol-Myers Squibb Company Put
|
|
|
|
|
|
|
|
| ARIA / ARIAD Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ARIA / ARIAD Pharmaceuticals, Inc. Call
|
|
|
|
|
|
|
|
| CYTK / Cytokinetics, Incorporated
|
|
|
|
|
|
|
|
| AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock) Call
|
|
|
|
|
|
|
|
| PFE / Pfizer Inc.
|
|
|
|
|
|
|
|
| PFE / Pfizer Inc. Call
|
|
|
|
|
|
|
|
| VIRX / Viracta Therapeutics, Inc.
|
|
|
|
|
|
|
|
